Bayesian cost‐effectiveness analysis from clinical trial data | Zendy

O'Hagan Anthony | Zendy; Stevens John W. | Zendy; Montmartin Jacques | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Bayesian cost‐effectiveness analysis from clinical trial data

Author(s) -

O'Hagan Anthony,

Stevens John W.,

Montmartin Jacques

Publication year - 2001

Publication title -

statistics in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.996

H-Index - 183

eISSN - 1097-0258

pISSN - 0277-6715

DOI - 10.1002/sim.861

Subject(s) - bayesian probability , computer science , inference , bayesian inference , bayesian experimental design , key (lock) , cost effectiveness analysis , bayesian statistics , econometrics , clinical trial , computation , statistics , data mining , cost effectiveness , medicine , artificial intelligence , mathematics , algorithm , computer security , pathology

A key tool for assessing the relative cost‐effectiveness of two treatments in health economics is the incremental C/E acceptability curve. We present Bayesian computations for this curve in the case where data on both costs and efficacy are available from a clinical trial. Analysis is given under various formulations of prior information. A case study is analysed in which reasonable prior information is shown to strengthen substantially the posterior inference, leading to a more conclusive assessment of cost‐effectiveness. Calculations can be performed using readily available Bayesian software. Copyright © 2001 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research